The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Items 201–400 of 657
The Natural History of Multiple Endocrine Neoplasia Type 1: Highly Uncommon or Highly Unrecognized?
Shepherd, J. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410320017001 · Cited by 163
Surgical treatment of mid‐gut carcinoid tumors
Makridis, C., Öberg, K., Juhlin, C., Rastad, J., Johansson, H., Lörelius, L. E., & Åkerström, G. (1990) · World Journal of Surgery · doi:10.1007/bf01658532 · Cited by 161
Medullary Thyroid Carcinoma: Recent Advances and Management Update
MARSH, D. J., Learoyd, D., & Robinson, B. G. (1995) · Thyroid · doi:10.1089/thy.1995.5.407 · Cited by 161
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
Eriksson, B., & Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s31 · Cited by 160
Somatostatin‐receptor Scintigraphy in Gastroenteropancreatic Tumors: An Overview of European Results
KRENNING, E. P., KWEKKEBOOM, D. J., OEI, H. Y., de JONG, R. J. B., DOP, F. J., REUBI, J. C., & LAMBERTS, S. W. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17291.x · Cited by 159
Gibril, F., Reynolds, J. C., Chen, C. C., Yu, F., Goebel, S. U., Serrano, J., Doppman, J. L., & Jensen, R. T. (1999) · PubMed · Cited by 159
Radiofrequency Tissue Ablation Using Cooled Tip for Liver Metastases of Endocrine Tumors
Hellman, P., Ladjevardi, S., Skogseid, B., Åkerström, G., & Elvin, A. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6663-3 · Cited by 159
Van Hoe, L., Gryspeerdt, S., Marchal, G., Baert, A. L., & Mertens, L. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.6.7484581 · Cited by 159
Semelka, R. C., Cumming, M. J., Shoenut, J. P., Magro, C. M., Yaffe, C. S., Kroeker, M. A., & Greenberg, H. M. (1993) · Radiology · doi:10.1148/radiology.186.3.8381551 · Cited by 159
HENNESSY, J. F., WELLS, S. A., ONTJES, D. A., & COOPER, C. W. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-3-487 · Cited by 158
MRI of pancreatic neuroendocrine tumours
Owen, N. J., Sohaib, S. A. A., Peppercorn, P. D., Monson, J. P., Grossman, A. B., Besser, G. M., & Reznek, R. H. (2001) · The British Journal of Radiology · doi:10.1259/bjr.74.886.740968 · Cited by 158
Self-citationTreatment of Neuroendocrine GEP Tumours with Somatostatin Analogues
Arnold, R., Simon, B., & Wied, M. (2000) · Digestion · doi:10.1159/000051861 · Cited by 157
Schlumberger, M. J., Gicquel, C., Lumbroso, J., Tenenbaum, F., Comoy, E., Bosq, J., Fonseca, E., Ghillani‐Dalbin, P., Aubert, B., Travagli, J. P., et al. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03345807 · Cited by 156
Insulin-Producing Islet Cell Tumors
Fajans, S. S., & Vinik, A. I. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30388-8 · Cited by 153
Chromogranin A: its clinical value as marker of neuroendocrine tumours.
Nobels, Kwekkeboom, Bouillon, & Lamberts (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00305.x · Cited by 151
Rigaud, G., Missiaglia, E., Moore, P. S., Zamboni, G., Falconi, M., Talamini, G., Pesci, A., Baron, A., Lissandrini, D., Rindi, G., et al. (2001) · PubMed · Cited by 150
Kress, O., Wagner, H., Wied, M., Klose, K.-J., Arnold, R., & Alfke, H. (2003) · Digestion · doi:10.1159/000074522 · Cited by 150
The Cushing Syndrome Induced by Bronchial Carcinoid Tumors
LIMPER, A. H., Carpenter, P. C., Scheithauer, B. W., & Staats, B. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-209 · Cited by 150
Wiedenmann, B., Jensen, R. T., Mignon, M., Modlin, C. I., Skogseid, B., Doherty, G., & Öberg, K. (1998) · World Journal of Surgery · doi:10.1007/s002689900387 · Cited by 149
Duodenal Carcinoids in Patients with and without Neurofibromatosis
Dayal, Y., Tallberg, K., Nunnemacher, G., DeLellis, R. A., & Wolfe, H. J. (1986) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198605000-00007 · Cited by 147
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
Örlefors, H., Sundín, A., Ahlström, H. K., Bjurling, P., Bergström, M., Lilja, A., Långström, B., Öberg, K., & Eriksson, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2534 · Cited by 147
Experience in treatment of metastatic pulmonary carcinoid tumors
Granberg, D. O., Eriksson, B., Wilander, E., Grimfjärd, P., Fjällskog, M.-L., Öberg, K., & Skogseid, B. M. (2001) · Annals of Oncology · doi:10.1023/a:1012569909313 · Cited by 147
Soga, J., & Yakuwa, Y. (1999) · PubMed · Cited by 146
Nagy, A., Schally, A. V., Halmos, G., Armatis, P. E., Cai, R., CSERNUS, V. J., Kovács, M., Koppán, M., Szepesházi, K., & Kahán, Z. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1794 · Cited by 146
Long‐term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s)
van Heerden, J. A., Roland, C. F., Carney, J. A., Sheps, S. G., & Grant, C. S. (1990) · World Journal of Surgery · doi:10.1007/bf01658516 · Cited by 146
Buscombe, J. R., Caplin, M. E., & Hilson, A. J. W. (2003) · PubMed · Cited by 143
Rectal and colonic carcinoids. A clinicopathologic study of 84 cases
Federspiel, B., BURKE, A. P., Sobin, L. H., & Shekitka, K. M. (1990) · Cancer · doi:10.1002/1097-0142(19900101)65:1<135::aid-cncr2820650127>3.0.co;2-a · Cited by 143
Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery.
Dn, D., Gorden, P., & Brennan, M. F. (1984) · PubMed · Cited by 142
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
van Hagen, P. M., Breeman, W. A. P., Bernard, H. F., Schaar, M., Mooij, C. M., Srinivasan, A., Schmidt, M. A., Krenning, E. P., & de Jong, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000820)90:4<186::aid-ijc2>3.0.co;2-p · Cited by 142
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.
Balon, H. R., Goldsmith, S. J., Siegel, B. A., Silberstein, E. B., Krenning, E. P., Lang, O., & Donohoe, K. J. (2001) · PubMed · Cited by 140
Patient noncompliance with self-administered chemotherapy
Lebovits, A. H., Strain, J. J., Messe, M. R., Schleifer, S. J., Tanaka, J. S., & Bhardwaj, S. (1990) · Cancer · doi:10.1002/1097-0142(19900101)65:1<17::aid-cncr2820650106>3.0.co;2-i · Cited by 139
Radiolabelled peptides for tumour therapy: current status and future directions
de Jong, M., Kwekkeboom, D. J., Valkema, R., & Krenning, E. P. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1107-8 · Cited by 138
Prognostic markers in pheochromocytoma
Clarke, M. R., Weyant, R. J., Watson, C. G., & Carty, S. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90070-3 · Cited by 138
Islet Cell Carcinoma of the Pancreas
Lo, C. Y., van Heerden, J. A., Thompson, G. B., Grant, C. S., Søreide, J. A., & Harmsen, W. S. (1996) · World Journal of Surgery · doi:10.1007/s002689900134 · Cited by 137
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry, L. J., Stuart, K. E., Stokes, K. R., & Clouse, M. E. (1994) · PubMed · Cited by 135
Drougas, J. G., Anthony, L. B., Blair, T. K., Lopez, R. R., Wright, J., Chapman, W. C., Webb, L., Mazer, M., Meranze, S. G., & Pinson, C. W. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00042-7 · Cited by 135
An Update of the Medical Treatment of Malignant Endocrine Pancreatic Tumors
Eriksson, B. K., & Öberg, K. (1993) · Acta Oncologica · doi:10.3109/02841869309083913 · Cited by 135
Neuroendocrine tumors of the pancreas and duodenum
Norton, J. A. (1994) · Current Problems in Surgery · doi:10.1016/0011-3840(94)90079-5 · Cited by 135
Location, incidence, and malignant potential of duodenal gastrinomas.
Thom, A. K., Norton, J. A., Axiotis, C. A., & Jensen, R. T. (1991) · PubMed · Cited by 134
Familial carcinoid tumors and subsequent cancers: A nation-wide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · International Journal of Cancer · doi:10.1002/ijc.1473 · Cited by 134
DIAGNOSTIC APPROACH TO ADULTS WITH HYPOGLYCEMIC DISORDERS
Service, F. J. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70086-4 · Cited by 133
ROY, P. K., VENZON, D. J., FEIGENBAUM, K. M., KOVIACK, P. D., BASHIR, S., OJEABURU, J. V., GIBRIL, F., & JENSEN, R. T. (2001) · Medicine · doi:10.1097/00005792-200105000-00005 · Cited by 133
Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels.
Mukherjee, J. J., Peppercorn, P. D., Reznek, R. H., Patel, V, Kaltsas, G., Besser, M., & Grossman, A. B. (1997) · Radiology · doi:10.1148/radiology.202.1.8988215 · Cited by 132
Self-citationBuetow, P. C., Miller, D. L., Parrino, T. V., & Buck, J. (1997) · Radiographics · doi:10.1148/radiographics.17.2.9084084 · Cited by 132
Neuroendocrine gastrointestinal tumors - A condensed overview of diagnosis and treatment
Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s3 · Cited by 132
MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION
Shapiro, B., Sisson, J. C., LLOYD, R., Nakajo, M., SATTERLEE, W. G., & Beierwaltes, W. H. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00074.x · Cited by 131
Clinicopathologic Studies of Thymic Carcinoids in Multiple Endocrine Neoplasia Type 1
Teh, B. T., McArdle, J., Chan, S. P., Menon, J., Hartley, L., Pullan, P., Ho, J., Khir, A., Wilkinson, S., Larsson, C., et al. (1997) · Medicine · doi:10.1097/00005792-199701000-00002 · Cited by 131
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
Janson, E. T., Ahlström, H. K., Andersson, T., & Öberg, K. E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90060-f · Cited by 130
Proye, C. A. G., Thévenin, D., Cécat, P., Petillot, P., Carnaille, B. M. L., Verin, P., Sautier, M., & Racadot-Leroy, N. (1989) · PubMed · Cited by 129
Extrapancreatic, Extraintestinal Gastrinoma: Effective Treatment by Surgery
Wolfe, M. M., ALEXANDER, R. W., & McGuigan, J. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062506 · Cited by 129
Klöppel, G., Heitz, P. U., Capella, C., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900021 · Cited by 128
Zuetenhorst, J. M., Bonfrer, J. M. G. M., Korse, C. M., Bakker, R., van Tinteren, H., & Taal, B. G. (2003) · Cancer · doi:10.1002/cncr.11226 · Cited by 126
Benya, R. V., Metz, D. C., Venzon, D. J., Fishbeyn, V. A., Strader, D. B., Orbuch, M., & Jensen, R. T. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90323-9 · Cited by 126
HSIAO, R. J., PARMER, R. J., TAKIYYUDDIN, M. A., & OʼCONNOR, D. T. (1991) · Medicine · doi:10.1097/00005792-199101000-00003 · Cited by 125
Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients
Pandya, U., Pellikka, P. A., Enriquez-Sarano, M. L., Edwards, W. D., Schaff, H. V., & Connolly, H. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02109-5 · Cited by 125
Surgical Management of Left-Sided Carcinoid Heart Disease
Connolly, H. M., Schaff, H. V., Mullany, C. J., Rubin, J., Abel, M., & Pellikka, P. A. (2001) · Circulation · doi:10.1161/hc37t1.094898 · Cited by 125
Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results
Koh, H. K., Caruso, A., Gage, I., Geller, A. C., Prout, M. N., White, H., O'connor, K., Balash, E. M., Blumental, G., Rex, I. H., et al. (1990) · Cancer · doi:10.1002/1097-0142(19900115)65:2<375::aid-cncr2820650233>3.0.co;2-z · Cited by 125
Mao, C., Shah, A., Hanson, D. J., & Howard, J. M. (1995) · Journal of Surgical Oncology · doi:10.1002/jso.2930590116 · Cited by 124
Natural History of Neuroendocrine Enteropancreatic Tumors
Mignon, M. (2000) · Digestion · doi:10.1159/000051856 · Cited by 124
Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment
Öberg, K. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00008 · Cited by 123
Sharma, K. H., Patel, Y., & Srikant, C. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0220 · Cited by 123
Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases.
Soga, J., & Yakuwa, Y. (1998) · PubMed · Cited by 122
Gastrointestinal Carcinoids: Characterization by Site of Origin and Hormone Production
Onaitis, M. W., Kirshbom, P. M., Hayward, T. Z., Quayle, F. J., Feldman, J. M., Seigler, H. F., & Tyler, D. S. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00010 · Cited by 122
Surgical Approach to Insulinomas: Assessing the Need for Preoperative Localization
Pasieka, J. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040088015 · Cited by 121
Norheim, I., THEODORSSON-NORHEIM, E., Brodin, E., & Öberg, K. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-605 · Cited by 121
Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome
Westberg, G., Wängberg, B., Ahlman, H. K., Bergh, C. ‐., Suurküla, M. B., & Caidahl, K. (2001) · British journal of surgery · doi:10.1046/j.0007-1323.2001.01798.x · Cited by 121
Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
Taal, B. G., Hoefnagel, C. A., Olmos, R. A. V., Boot, H., & Beijnen, J. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1829 · Cited by 121
Trendle, M. C., Moertel, C. G., & Kvols, L. K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<830::aid-cncr20>3.0.co;2-# · Cited by 120
Carcinoid syndrome: a statistical evaluation of 748 reported cases.
Soga, J., Yakuwa, Y., & Osaka, M. (1999) · PubMed · Cited by 119
Diagnostic value of plasma chromogranin A in neuroendocrine tumours
Tomassetti, P., Migliori, M., Simoni, P., Casadei, R., De Iasio, R., Corinaldesi, R., & Gullo, L. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200101000-00010 · Cited by 119
Cadiot, G., Lebtahi, R., Sarda‐Mantel, L., Bonnaud, G., Marmuse, J., Vissuzaine, C., Ruszniewski, P. B., Guludec, D. L., & Mignon, M. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70052-5 · Cited by 119
Hepatic Arterial Chemoembolization in the Management of Advanced Digestive Endocrine Tumors
Ruszniewski, P., & Malka, D. (2000) · Digestion · doi:10.1159/000051860 · Cited by 118
Goblet cell carcinoid of the appendix
Butler, J., Houshiar, A. M., Lin, F., & Wilson, S. E. (1994) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80145-x · Cited by 118
Clinical Features, Diagnosis, and Localization of Carcinoid Tumors and Their Management
Vinik, A. I., McLeod, M. K., Fig, L. M., Shapiro, B., Lloyd, R. V., & Cho, K. (1989) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00446-5 · Cited by 118
Neuroendocrine neoplasms of the bronchopulmonary tract
Warren, W. H., Gould, V. E., Faber, L. P., Kittle, C. F., & Memoli, V. A. (1985) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38687-8 · Cited by 118
Nonfunctioning islet cell carcinoma of the pancreas.
Evans, D. B., Skibber, J. M., Lee, J. E., Cleary, K. R., Ajani, J. A., Gagel, R. F., Sellin, R. V., Fenoglio, C. J., Merrell, R. C., & Hickey, R. C. (1993) · PubMed · Cited by 117
Carcinoids: The association of histologic growth pattern and survival
Johnson, L. A., Lavin, P. T., Moertel, C. G., Weiland, L. H., Dayal, Y., Doos, W. G., Geller, S. A., Cooper, H. S., Nime, F. A., Massé, S., et al. (1983) · Cancer · doi:10.1002/1097-0142(19830301)51:5<882::aid-cncr2820510522>3.0.co;2-8 · Cited by 117
Faiss, S., Räth, U., Mansmann, U., Caird, D. M., Clemens, N., Riecken, E. O., & Wiedenmann, B. (1999) · Digestion · doi:10.1159/000007693 · Cited by 116
Somatostatin and somatostatin analogues: diagnostic and therapeutic uses
de Herder, W. W., & Lamberts, S. W. J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00010 · Cited by 116
Kebebew, E., Kikuchi, S., Duh, Q. Y., & Clark, O. H. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.8.895 · Cited by 116
Lamberts, S. W. J., Hofland, L. J., & Nobels, F. R. E. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0218 · Cited by 115
Diaco, D. S., Hajarizadeh, H., Mueller, C. R., Fletcher, W. S., Pommier, R. F., & Woltering, E. A. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80210-4 · Cited by 115
Pulmonary and Thymic Carcinoid Tumors
Dusmet, M. E., & McKneally, M. F. (1996) · World Journal of Surgery · doi:10.1007/s002689900029 · Cited by 114
Surgery for Asymptomatic Pancreatic Lesion in Multiple Endocrine Neoplasia Type I
Skogseid, B., Öberg, K., Eriksson, B., Juhlin, C., Granberg, D., Åkerström, G., & Rastad, J. (1996) · World Journal of Surgery · doi:10.1007/s002689900133 · Cited by 114
Improved Results of Cervical Reoperation for Medullary Thyroid Carcinoma
Moley, J. F., Dilley, W. G., & DeBenedetti, M. K. (1997) · Annals of Surgery · doi:10.1097/00000658-199706000-00011 · Cited by 114
Ruszniewski, P. B., Amouyal, P., Amouyal, G., Grangé, J., Mignon, M., Bouché, O., & Bernades, P. (1995) · Surgery · doi:10.1016/s0039-6060(95)80005-0 · Cited by 113
Advances and Controversies in the Diagnosis and Management of Medullary Thyroid Carcinoma
Heshmati, H. M., Gharib, H., van Heerden, J. A., & Sizemore, G. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00024-7 · Cited by 113
Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)
Olsen, J. O., Pozderac, R. V., Hinkle, G. H., Hill, T., O’Dorisio, T. M., Schirmer, W. J., Ellison, E. C., & O'Dorisio, M. S. (1995) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(95)80014-x · Cited by 112
Immunotherapy for Medullary Thyroid Carcinoma by Dendritic Cell Vaccination
Schott, M., Seißler, J., Lettmann, M., Fouxon, V., Scherbaum, W. A., & Feldkamp, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7949 · Cited by 112
Chemotherapy in the Treatment of Neuroendocrine Malignant Tumors
Rougier, P. R., & Mitry, E. (2000) · Digestion · doi:10.1159/000051859 · Cited by 111
Nuclear medicine imaging of neuroendocrine tumours
Bombardieri, E., Maccauro, M., de Deckere, E. R. J. T., Savelli, G., & Chiti, A. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s51 · Cited by 111
Corbetta, S., Peracchi, M., Cappiello, V., Lania, A., Lauri, E., Vago, L., Beck-Peccoz, P., & Spada, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021842 · Cited by 110
A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung
Schreurs, A. J. M., Westermann, C. J. J., van den Bosch, J. M. M., Vanderschueren, R. G. J. R. A., de la Rivière, A. B., & Knaepen, P. J. (1992) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)34645-8 · Cited by 110
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours
Tomassetti, P., Migliori, M., Lalli, S., Campana, D., Tomassetti, V., & Corinaldesi, R. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s95 · Cited by 109
The Role of PET in Localization of Neuroendocrine and Adrenocortical Tumors
ERIKSSON, B., BERGSTRÖM, M., SUNDIN, A., JUHLIN, C., ÖRLEFORS, H., ÖBERG, K., & LÅNGSTRÖM, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04422.x · Cited by 109
Pheochromocytoma--continuing evolution of surgical therapy.
Orchard, T. J., Grant, C. S., van Heerden, J. A., & Weaver, A. L. (1993) · PubMed · Cited by 108
Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.
Sutliff, V. E., Doppman, J. L., Gibril, F., Venzon, D. J., Yu, F., Serrano, J., & Jensen, R. T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2420 · Cited by 108
King, C., Reznek, R. H., Dacie, J. E., & Wass, J. A. H. (1994) · Clinical Radiology · doi:10.1016/s0009-9260(05)81790-8 · Cited by 107
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors
Ansell, S. M., Pitot, H. C., Burch, P. A., Kvols, L. K., Mahoney, M. R., & Rubin, J. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n · Cited by 107
Reubi, J. C., Laissue, J. A., Waser, B., Horisberger, U., & Schaer, J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17262.x · Cited by 106
Tanaka, S., Yamasaki, S., Matsushita, H., Ozawa, Y., Kurosaki, A., Takeuchi, K., Hoshihara, Y., Doi, T., Watanabe, G., & Kawaminami, K. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01016.x · Cited by 105
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids
Granberg, D., Wilander, E., Stridsberg, M., Granerus, G., Skogseid, B., & Öberg, K. (1998) · Gut · doi:10.1136/gut.43.2.223 · Cited by 105
Kraeber‐Bodéré, F., Bardet, S., Hoefnagel, C. A., Vieira, M. R., Vuillez, J.-P., Murat, A., Ferreira, T. C., Bardiès, M., Ferrer, L., Resche, I., et al. (1999) · PubMed · Cited by 105
Goblet Cell Carcinoids of the Appendix: Immunophenotype and Ultrastructural Study
Kanthan, R., Saxena, A., & Kanthan, S. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0386-gccota · Cited by 105
Wynick, D., Hammond, P. J., & Bloom, S. R. (1993) · Clinics in Dermatology · doi:10.1016/0738-081x(93)90103-j · Cited by 105
The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.
Ponder, B. A. (1999) · PubMed · Cited by 104
Treatment of malignant pheochromocytoma with combination chemotherapy.
Keiser, H. R., Goldstein, D. S., Wade, J. L., Douglas, F. L., & Averbuch, S. D. (1985) · Hypertension · doi:10.1161/01.hyp.7.3_pt_2.i18 · Cited by 104
Grama, D., Skogseid, B., Wilander, E., Eriksson, B., Mårtensson, H., Cedermark, B., Ahrén, B., Kristofferson, A., Öberg, K., Rastad, J., et al. (1992) · World Journal of Surgery · doi:10.1007/bf02067335 · Cited by 104
Nguyen, A. P., Schaff, H. V., & Connolly, H. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-24174-2_51 · Cited by 104
The epidemiology of carcinoid tumours in England and Scotland
Newton, J. N., Swerdlow, A. J., Silva, I. D. S., Vessey, M., Grahame‐Smith, D., Primatesta, P., & Reynolds, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.424 · Cited by 102
New advances in peptide receptor radionuclide therapy.
de Jong, M., & Krenning, E. (2002) · PubMed · Cited by 102
Slow-Release Lanreotide Treatment in Endocrine Gastrointestinal Tumors
Tomassetti, P., Migliori, M., & Gullo, L. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.465_q.x · Cited by 101
Antiangiogenic effects of somatostatin analogues
de la Torre, N. G., Wass, J. A. H., & Turner, H. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01619.x · Cited by 101
Skogseid, B. M., Öberg, K., Benson, L., Lindgren, P. G., Lörelius, L. ‐., Lundquist, G., WIDE, L. E., & Wilander, E. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1233 · Cited by 101
Mahler, C., Verhelst, J. A., Longueville, M. D., & Harris, A. G. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00490.x · Cited by 100
Current diagnosis and management of medullary thyroid carcinoma
Giuffrida, D., & Gharib, H. (1998) · Annals of Oncology · doi:10.1023/a:1008242302749 · Cited by 100
Long-Acting Depot Lanreotide in the Treatment of Patients With Advanced Neuroendocrine Tumors
Ricci, S., Antonuzzo, A., Galli, L., Orlandini, C., Ferdeghini, M., Boni, G., Roncella, M., Mosca, F., & Conte, P. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200008000-00020 · Cited by 100
Hofland, L. J., van Koetsveld, P. M., Waaijers, M., Zuyderwijk, J., Breeman, W. A. P., & Lamberts, S. W. J. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649075 · Cited by 100
New somatostatin analogs: will they fulfil old promises?
Lamberts, S., van der Lely, A., & Hofland, L. J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460701 · Cited by 100
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
Debray, M., Geoffroy, O., Laissy, J., Lebtahi, R., Silbermann-Hoffman, O., Henry–Feugeas, M.-C., Cadiot, G., Mignon, M., & Schouman‐Claeys, E. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.887.741065 · Cited by 100
Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide
Filosso, P. L., Ruffini, E., Oliaro, A., Papalia, E., Donati, G., & Rena, O. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(02)00055-6 · Cited by 99
Carcinoids of the ovary: an analysis of 329 reported cases.
Soga, J., Osaka, M., & Yakuwa, Y. (2000) · PubMed · Cited by 99
Bukowski, R. M., Johnson, K. G., Peterson, R. F., Stephens, R. L., Rivkin, S. E., Neilan, B. A., & Costanzi, J. H. (1987) · Cancer · doi:10.1002/1097-0142(19871215)60:12<2891::aid-cncr2820601207>3.0.co;2-6 · Cited by 98
GRIFFITHS, D. F. R., Williams, G. T., & Williams, E. D. (1987) · QJM · doi:10.1093/oxfordjournals.qjmed.a068147 · Cited by 97
Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases.
Soga, J. (2003) · PubMed · Cited by 96
Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia
Gough, D. B., Thompson, G. B., Crotty, T. B., Donohue, J. H., Kvols, L. K., Carney, J. A., Grant, C. S., & Nagorney, D. M. (1994) · World Journal of Surgery · doi:10.1007/bf00353739 · Cited by 96
Impact of chromogranin A measurement in the work-up of neuroendocrine tumors
Baudin, É., Bidart, J., Bachelot, A., Ducreux, M. P., Elias, D. M., Ruffiè, P., & Schlumberger, M. J. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s79 · Cited by 95
Biochemical Diagnosis of Pheochromocytoma
Eisenhofer, G., Lenders, J. W. M., & Pacák, K. (2003) · KARGER eBooks · doi:10.1159/000074659 · Cited by 95
Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues
Wiseman, G. A., & Kvols, L. K. (1995) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(95)80016-6 · Cited by 94
Genetic Testing in the Diagnosis and Management of Multiple Endocrine Neoplasia Type II
Ledger, G. A., Khosla, S., Lindor, N. M., Thibodeau, S. N., & Gharib, H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-2-199501150-00008 · Cited by 94
Treatment of medullary thyroid carcinoma: an update.
Orlandi, F., Caraci, P., Mussa, A., Saggiorato, E., Pancani, G., & Angeli, A. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080135 · Cited by 94
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria, S., Vergara, E., Palmieri, G., Acampa, W., Varrella, P., Caracò, C., Bianco, R. A., Muto, P., & Salvatore, M. (1998) · PubMed · Cited by 94
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours
Angeletti, S., Corleto, V. D., Schillaci, O., Marignani, M., Annibale, B., Moretti, A., Silecchia, G., Scopinaro, F., Basso, N., Bordi, C., et al. (1998) · Gut · doi:10.1136/gut.42.6.792 · Cited by 93
Neuroendocrine tumours of the pancreas
Eriksson, B., & Öberg, K. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01277.x · Cited by 93
Malignant Pheochromocytoma: Chromaffin Granule Transmitters and Response to Treatment
Rao, F., Keiser, H. R., & O’Connor, D. T. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.1045 · Cited by 93
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria, S., Vergara, E., Palmieri, G., et al. (1998) · PubMed · Cited by 93
Classification of hypoglycemic disorders.
Service, F. J. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70085-2 · Cited by 92
Thirty years' experience with gastrinoma
Zollinger, R. M., Ellison, E. C., O’Dorisio, T. M., & Sparks, J. (1984) · World Journal of Surgery · doi:10.1007/bf01654904 · Cited by 92
Standardisation of imaging in neuroendocrine tumours: results of a European delphi process
Ricke, J., Klose, K.-J., Mignon, M., Öberg, K., & Wiedenmann, B. (2001) · European Journal of Radiology · doi:10.1016/s0720-048x(00)00187-x · Cited by 92
SURGICAL CONSIDERATIONS AND APPROACH TO THYROID CANCER
Soh, E. Y., & Clark, O. H. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70315-7 · Cited by 92
Öberg, K., Norheim, I., Lundqvist, G., & WIDE, L. E. (1987) · Acta Oncologica · doi:10.3109/02841868709113712 · Cited by 92
Rivera, E., & Ajani, J. A. (1998) · American Journal of Clinical Oncology · doi:10.1097/00000421-199802000-00008 · Cited by 92
METZ, D. C., STRADER, D. B., ORBUCH, M., KOVIACK, P. D., FEIGENBAUM, K. M., & JENSEN, R. T. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00140.x · Cited by 92
Omura, G., Morrow, C. P., Blessing, J. A., Miller, A., Buchsbaum, H. J., Homesley, H. D., & Leone, L. A. (1983) · Cancer · doi:10.1002/1097-0142(19830301)51:5<851::aid-cncr2820510518>3.0.co;2-y · Cited by 91
Use ofm-[131I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., CARPENTIER, P., Fleury-Goyon, M. C., Gibold, C., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-455 · Cited by 91
Clinical experience with malignant pheochromocytomas.
Scott, H. W., Reynolds, V., Green, N., Page, D. L., Oates, J. A., Robertson, D., & Roberts, S. (1982) · PubMed · Cited by 91
Localization of insulinomas by selective intraarterial calcium injection
O'Shea, D. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1623 · Cited by 90
Ricci, S., Antonuzzo, A., Galli, L., Ferdeghini, M., Bodei, L., Orlandini, C., & Conte, P. (2000) · Annals of Oncology · doi:10.1023/a:1008383132024 · Cited by 90
Maurea, S., Cuocolo, A., Reynolds, J. C., Neumann, R. D., & Salvatore, M. (1996) · PubMed · Cited by 89
Endoscopic ultrasound for localisation of islet cell tumours.
Glover, J. R., Shorvon, P. J., & Lees, W. R. (1992) · Gut · doi:10.1136/gut.33.1.108 · Cited by 88
The role of interferons in the management of carcinoid tumours
Öberg, K., & Eriksson, B. K. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08125.x · Cited by 88
Höpfner, M., Sutter, A. P., Gerst, B., Zeitz, M., & Scherübl, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601346 · Cited by 88
Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors
Bansal, R., Tierney, W., Carpenter, S. L., Thompson, N. W., & Scheiman, J. M. (1999) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(99)70440-2 · Cited by 88
New advances in peptide receptor radionuclide therapy.
de Jong, M., & Krenning, E. P. (2002) · PubMed · Cited by 88
Canguilhem, G. (1978) · Springer eBooks · doi:10.1007/978-94-009-9853-7_12 · Cited by 87
Treatment of Malignant Pheochromocytomas With 131-I Metaiodobenzylguanidine and Chemotherapy
Sisson, J. C., Shapiro, B., Shulkin, B. L., Urba, S. G., Zempel, S., & Spaulding, S. (1999) · American Journal of Clinical Oncology · doi:10.1097/00000421-199908000-00008 · Cited by 87
Carcinoid Tumors: Imaging Procedures and Interventional Radiology
Wallace, S., Ajani, J. A., Charnsangavej, C., DuBrow, R. A., Yang, D. J., Chuang, V. P., Carrasco, C. H., & Dodd, G. D. (1996) · World Journal of Surgery · doi:10.1007/s002689900023 · Cited by 87
Machens, A., Holzhausen, H.-J., Thanh, P. N., & Dralle, H. (2003) · Surgery · doi:10.1067/s0039-6060(03)00157-0 · Cited by 87
Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.
Fjälling, M., Andersson, P., Forssell-Aronsson, E. B., Grétarsdóttir, J., Johansson, V., Tisell, L. E., Wängberg, B., Nilsson, O., Berg, G., Michanek, A., et al. (1996) · PubMed · Cited by 87
Incidence and mortality of carcinoids of the colon. Data from the connecticut tumor registry
Ballantyne, G. H., Savaca, P. E., Flannery, J., Ahlman, M., & Modlin, I. M. (1992) · Cancer · doi:10.1002/1097-0142(19920515)69:10<2400::aid-cncr2820691003>3.0.co;2-z · Cited by 87
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.
Breeman, W. A., Kwekkeboom, D. J., Kooij, P. P. M., Bakker, W. H., Hofland, L. J., Visser, T. J., Ensing, G. J., Lamberts, S. W. J., & Krenning, E. P. (1995) · PubMed · Cited by 86
Small bowel neoplastic disease: Demonstration by MRI
Semelka, R. C., John, G., Kelekis, N., Burdeny, D. A., & Ascher, S. M. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060603 · Cited by 86
Benali, N. L., Ferjoux, G., Puente, E., Buscail, L., & Susini, C. (2000) · Digestion · doi:10.1159/000051852 · Cited by 86
Hajarizadeh, H., Ivancev, K., Mueller, C. R., Fletcher, W. S., & Woltering, E. A. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90392-5 · Cited by 85
Thymic carcinoids in multiple endocrine neoplasia type 1
Teh, B. T. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00329.x · Cited by 85
Engelbach, M., Görges, R., Forst, T. M., Pfützner, A., Dawood, R. M., Heerdt, S., Kunt, T., Bockisch, A., & Beyer, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6601 · Cited by 85
Radiofrequency Ablation: a Novel Approach for Treatment of Metastatic Pheochromocytoma
Pacák, K., Fojo, T., Goldstein, D. S., Eisenhofer, G., Walther, M. M., Linehan, W. M., Bachenheimer, L. C., Abraham, J., & Wood, B. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.648 · Cited by 85
German medullary thyroid carcinoma/multiple endocrine neoplasia registry
Raue, F. (1998) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050143 · Cited by 85
The Ki67 index a prognostic marker in medullary thyroid carcinoma
Tisell, L. E., Odén, A., Muth, A., Altiparmak, G., Mölne, J., Ahlman, H. K., & Nilsson, O. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601453 · Cited by 84
Jensen, R. T. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00015 · Cited by 84
Prognostic Markers in Patients with Typical Bronchial Carcinoid Tumors
Granberg, D. O., Wilander, E., Öberg, K., & Skogseid, B. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6785 · Cited by 84
Juweid, M. E., Hajjar, G., Swayne, L. C., Sharkey, R. M., Suleiman, S., Herskovic, T., Pereira, M. A., Rubin, A. D., & Goldenberg, D. M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1828::aid-cncr25>3.0.co;2-h · Cited by 84
Garland, J., Buscombe, J. R., Bouvier, C., Bouloux, P. M., Chapman, M. H., Chow, A. C., Reynolds, N., & Caplin, M. E. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01420.x · Cited by 83
Soga, J., Yakuwa, Y., & Osaka, M. (1999) · PubMed · Cited by 81
Janson, E., Stridsberg, M., Gobl, A., Westlin, J.-E., & Öberg, K. (1998) · PubMed · Cited by 81
How does interferon exert its cell growth inhibitory effect?
Grandér, D., Sangfelt, O., & Erickson, S. (1997) · European Journal of Haematology · doi:10.1111/j.1600-0609.1997.tb00965.x · Cited by 81
Biological and Molecular Aspects of Gastroenteropancreatic Neuroendocrine Tumors
Rindi, G., Villanacci, V., & Ubiali, A. (2000) · Digestion · doi:10.1159/000051851 · Cited by 81
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease
Robiolio, P. A., Rigolin, V. H., Harrison, J. K., Lowe, J. E., Moore, J. O., Bashore, T. M., & Feldman, J. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80586-4 · Cited by 81
Tsagarakis, S., Christoforaki, M., Giannopoulou, H., Rondogianni, F., Housianakou, I., Malagari, C., Rontogianni, D., Bellenis, I., & Thalassinos, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030525 · Cited by 80
Fjällskog, M.-L., Sundin, A., Westlin, J. E., Öberg, K., Janson, E. T., & Eriksson, B. K. (2002) · Medical Oncology · doi:10.1385/mo:19:1:35 · Cited by 80
Management of Pheochromocytoma
Shapiro, B., & Fig, L. M. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30378-5 · Cited by 79
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma
Abdelmoumene, N., Schlumberger, M. J., Gardet, P., Roche, A., Travagli, J. P., Francese, C., & Parmentier, C. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.224 · Cited by 79
Malignant pheochromocytoma: A series of 14 cases observed between 1966 and 1990
Mornex, R., Badet, C., & Peyrin, L. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03345808 · Cited by 79
Kebebew, E., & Clark, O. H. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0052-7 · Cited by 79
Somatostatin receptor subtype expression in human tumors
Hofland, L. J., & Lamberts, S. W. J. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s31 · Cited by 79
Funa, N. S., Papanicolaou, V., Juhlin, C., Rastad, J., Åkerström, G., Heldin, C. H., & Öberg, K. (1990) · PubMed · Cited by 78
Smith, M. C., Liu, J., Chen, T., SCHRAN, H. F., Yeh, C., Jamar, F., Valkema, R., Bakker, W. H., Kvols, L. K., Krenning, E. P., et al. (2000) · Digestion · doi:10.1159/000051858 · Cited by 78
Pheochromocytoma and functional paraganglioma
Yeo, H., & Roman, S. A. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000147900.12325.d9 · Cited by 78
Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours
JAÏS, P., TERRIS, B., RUSZNIEWSKI, P., LeROMANCER, M., REYL‐DESMARS, F., VISSUZAINE, C., CADIOT, G., MIGNON, M., & LEWIN, M. J. M. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1740719.x · Cited by 78
Update on the Diagnosis and Treatment of Rare Neuroendocrine Tumors
Friesen, S. R. (1987) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)44190-3 · Cited by 78
Molecular Genetics of Neuroendocrine Tumors
Calender, A. (2000) · Digestion · doi:10.1159/000051850 · Cited by 77
Rosenberg, J., & Welch, J. P. (1985) · The American Journal of Surgery · doi:10.1016/s0002-9610(85)80184-7 · Cited by 76
Modlgliani, E., Cohen, R., Joannldis, S., Slame‐Mourot, C., Guliana, J. M., Charpentier, G., Cassuto, D.-A., Bentata-Pessayre, M., Tabarin, A., Roger, P., et al. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb00955.x · Cited by 76
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix.
Seckl, M. J., Mulholland, P. J., Bishop, A. E., Teale, J. D., Hales, C. N., Glaser, M., Watkins, S., & Seckl, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411004 · Cited by 75
Vitale, G., Tagliaferri, P., Caraglia, M., Rampone, E., Ciccarelli, A., Bianco, A. R., Abbruzzese, A., & Lupoli, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6435 · Cited by 75
O’Dorisio, T. M., Mekhjian, H. S., & Gaginella, T. S. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30381-5 · Cited by 75
Brauch, H., Hoeppner, W., Jähnig, H., Wöhl, T., Engelhardt, D., Spelsberg, F., & Ritter, M. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4454 · Cited by 74
Endoscopic assessment of invasion of colorectal tumors with a new high-frequency ultrasound probe
Yoshida, M., Tsukamoto, Y., Niwa, Y., Goto, H., Hase, S., Hayakawa, T., & Okamura, S. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70196-6 · Cited by 74
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citation
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.